02.05.2018 • News

H.I.G. Capital Takes Control of Brazil’s Elekeiroz

H.I.G. Capital Takes Control of Brazil’s Elekeiroz (c) parema/Getty Images
H.I.G. Capital Takes Control of Brazil’s Elekeiroz (c) parema/Getty Images

An affiliate of US private equity group H.I.G. Capital has signed an agreement to acquire Brazilian chemical producer Elekeiroz from that company’s controlling shareholder, Itaúsa-Investimentos Itaú. H.I.G. Capital will initially acquire 96.5% of Elekeiroz’s shares and said it plans to acquire the remainder as soon as possible.

Elekeiroz is the sole manufacturer of oxo alcohols in Latin America and the largest producer of plasticizers in Brazil, also producing phthalic anhydride, maleic anhydride, sulfuric acid and other byproducts. The company operates two sites in Brazil, at Várzea Paulista and Camaҫari in Bahia.

Fernando Marques Oliveira, managing director and head of H.I.G. Latin America, said: “The management team has done a terrific job in building a leadership position across all its products, and H.I.G. will now support the company in its organic and inorganic growth plans as well as cost efficiency projects.”

Elekeiroz’s CEO, Marcos De Marchi, and the management team will remain with the company.

Separately, Vantage Specialty Chemicals Holdings, a portfolio company of H.I.G. Capital, has acquired B&B Tritech for an undisclosed sum. Located in Hialeah, Florida, USA, B&B makes surface treatment solutions for defense and commercial aviation markets, including paint removers and cleaners.

Richard McEvoy, Vantage’s CEO, said B&B is an excellent strategic fit with its Performance Materials division and offers complementary products for the growing aerospace segment.

B&B is the first bolt-on acquisition that Vantage has completed since it was acquired by H.I.G. in October 2017.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.